• 隐私保护和数据安全成为数字时代的重要议题。
  • 全球健康危机促使各国加强公共卫生体系的建设。
  • 网络安全问题日益严重,个人数据保护成为公众关注的焦点。
  • 自动化和机器人技术在制造业中的应用提高了生产效率。
  • 随着人工智能技术的不断进步,机器学习正在成为教育领域的新趋势。
  • 电子商务的快速发展对传统零售业造成了巨大冲击。
  • 大数据在商业决策和市场预测中的作用日益凸显。
  • 社交媒体对年轻一代的影响力日益增强,引发对网络文化和心理健康的讨论。
  • 全球变暖问题促使各国加强减排和绿色能源的推广。
  • 加密货币市场的波动性引起了投资者和监管机构的密切关注。
  • 5G技术的快速发展为智能城市和物联网提供了强大的网络基础。
  • 在这个快速变化的时代,保持学习和适应的能力是成功的关键。
  • 在线教育的兴起为全球学习者提供了更多样化的学习资源和途径。
  • 随着人们对健康意识的提高,健康食品和生活方式受到更多关注。
  • 加密货币市场的波动引发了对金融监管的新讨论。
  • 社交媒体在社会运动和政治变革中扮演了重要角色。
  • 5G网络的普及为物联网和智能设备提供了更广阔的应用空间。
  • 虚拟现实和增强现实技术在教育和娱乐领域的应用不断拓展。
  • 智能家居设备的发展正在改变人们的生活方式。
  • 电子商务的快速发展对传统零售业造成了巨大冲击。
  • 海洋塑料污染问题激发了全球范围内的环保意识和行动。
  • 科技创新正在推动教育方式的变革。
  • 随着全球健康危机的持续,公共卫生体系的完善成为紧迫议题。
  • 环保意识的提升促使消费者更倾向于购买可持续产品。
  • 电子竞技的流行正在改变传统体育和娱乐行业的格局。
  • Application and research progress of BCL2 inhibitors in elderly patients with hematologic malignancies | Wang | Aging Pathobiology and Therapeutics

    Application and research progress of BCL2 inhibitors in elderly patients with hematologic malignancies

    Yufan Wang, Liang Wang

    Abstract


    Apoptosis is a process of programmed cell death which mediated by proteases called caspases. Deregulated apoptosis is the basis of a variety of diseases, including cancer. The pathways of apoptosis can be divided into two independent signaling pathways, intrinsic or extrinsic. B-cell lymphoma 2 family proteins including BCL2 anti-apoptotic protein play an important role in the regulation of caspases in intrinsic pathways. Since that BCL2 is often overexpressed in cancer cells, a series of inhibitors targeting the BCL2 family antiapoptotic proteins have been developed to induce apoptosis in cancer cells. The highly selective BCL2 inhibitors, such as venetoclax (ABT-199, Venclexta™) and navitoclax(ABT-263), have shown good efficacy and safety in many hematologic malignancies. Considering that elderly patients with hematological malignancies still lack effective treatments, BCL2 inhibitors are undoubtedly an attractive new therapy due to their desirable safety and efficacy. This article reviews the application and research progress of BCL2 inhibitors in elderly patients with hematologic malignancies.

    Keywords: BCL2 inhibitors, hematologic malignancies, venetoclax, elderly patients




    Subscribe to receive issue release notifications
    and newsletters from journals